Genentech's Anderson to succeed O'Day at Roche

Genentech Inc. CEO Bill Anderson will succeed Daniel O’Day as the CEO of the pharmaceuticals division of Roche (SIX:ROG; OTCQX:RHHBY)

Read the full 201 word article

User Sign In